Ivzact 1.125gm Injection
Marketer
Zanetaz Medicorp
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Ivzact 1.125gm Injection
Combiflox 1.125g Injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this injection requires adherence to the prescribed schedule; complete the full course regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), generally resolving spontaneously. However, worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions, manifested as skin rashes, itching, swelling, or respiratory distress. Prior to commencing treatment, disclose all current medications and pre-existing health conditions to your physician. This is especially important for pregnant or lactating individuals. Alcohol consumption should be avoided due to the potential for increased drowsiness. While typically non-impairing, refrain from driving if experiencing drowsiness or dizziness.
Primary Ingredients of Ivzact 1.125gm Injection
No text was provided to rewrite.
Uses of Ivzact 1.125gm Injection
Infections caused by bacteria
Major Benefits of Ivzact 1.125gm Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Ivzact 1.125gm Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Ivzact 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ivzact 1.125gm Injection works:
The injectable formulation Ivzact 1.125gm combines cefepime, an antibiotic disrupting bacterial cell wall synthesis crucial for their viability, with tazobactam, a beta-lactamase inhibitor. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thereby broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ivzact 1.125gm Injection concurrently with alcohol. Seek medical advice.
PregnancySAFE IF PRESCRIBED
The injectable medication Ivzact, 1.125gm dose, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Ivzact (1.125 gm) is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Following administration of a 1.125-gram Ivzact injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Patients with kidney impairment should use Ivzact 1.125gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of a 1.125-gram Ivzact injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Ivzact 1.125gm Injection :
Omit a scheduled Ivzact 1.125gm Injection? Seek your physician's advice.
Facts to Know About Ivzact 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently